DAK HEALTH has floated a tender for Completion of a Non-exclusive Discount Agreement According to § 130a Para. 8 Sgb V to the Active Substance Insulin Lispro, Atc A10ab04 and A10ad04 for the Time 01.01.2022 - 31.12.2023. The project location is Germany and the tender is closing on 05 Nov 2023. The tender notice number is -, while the TOT Ref Number is 60118226. Bidders can have further information about the tender and can request the complete tender document by Registering on the site.

Procurement Summary

Country : Germany

Summary : Completion of a Non-exclusive Discount Agreement According to § 130a Para. 8 Sgb V to the Active Substance Insulin Lispro, Atc A10ab04 and A10ad04 for the Time 01.01.2022 - 31.12.2023

Deadline : 05 Nov 2023

Other Information

TOT Ref.No.: 60118226

Document Ref. No. : xxxxxxxxx

Competition : ICB

Financier : Self Financed

Purchaser's Detail

Name :xxxxxxxxx

Address : xxxxxxxxx

Email : xxxxxxxxx

Login to see details